Trial intelligence / Profile preview

Megestrol Acetate for Weight Loss in Dementia

NCT00503516Phase 3Terminated

Sponsor
Rottapharm Biotech
Start
Jun 2007
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of megestrol in Malnutrition, sponsored by Rottapharm Biotech. Started Jun 2007; status: terminated.

02

Drugs

megestrol
03

Conditions

Malnutrition

Beyond the preview

Go deeper on NCT00503516.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00503516.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call